News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
FINCK BARBARA K
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
4/A
| FINCK BARBARA K (Director) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Bought 6,756 shares
@ $1.23, valued at
$8.3k
Bought 6,756 warrants
@ $0.25, valued at
$1.7k
|
|
| 01/06/2023 |
4
| FINCK BARBARA K (Director) has filed a Form 4 on Comera Life Sciences Holdings, Inc.|
Txns:
| Granted 6,756 shares
@ $1.23, valued at
$8.3k
Granted 6,756 warrants
@ $0.25, valued at
$1.7k
|
|
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/16/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/12/2018 |
4
| FINCK BARBARA K (Chief Medical Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Sold 1,760 shares
@ $18.5789, valued at
$32.7k
Exercised 1,760 options to buy
@ $1.42, valued at
$2.5k
|
|
| 08/15/2018 |
4
| FINCK BARBARA K (Chief Medical Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Sold 1,760 shares
@ $19.0227, valued at
$33.5k
Exercised 1,760 options to buy
@ $1.42, valued at
$2.5k
|
|
| 07/11/2018 |
4
| FINCK BARBARA K (Chief Medical Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Sold 500 shares
@ $15.03, valued at
$7.5k
Sold 1,260 shares
@ $15, valued at
$18.9k
Exercised 500 options to buy
@ $1.42, valued at
$710
Exercised 1,260 options to buy
@ $1.42, valued at
$1.8k
|
|
| 06/20/2018 |
4
| FINCK BARBARA K (Chief Medical Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Sold 1,760 shares
@ $15, valued at
$26.4k
Exercised 1,760 options to buy
@ $1.42, valued at
$2.5k
|
|
| 02/05/2018 |
4
| FINCK BARBARA K (Chief Medical Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 130,000 options to buy
@ $10.05, valued at
$1.3M
|
|
| 12/19/2017 |
4
| FINCK BARBARA K (Chief Medical Officer) has filed a Form 4 on Coherus BioSciences, Inc.|
Txns:
| Granted 7,545 shares
@ $0 |
|
| 08/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|